Pinnacle Financial Group, Inc.’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.6K Buy
+984
New +$4.45K ﹤0.01% 1806

Other funds holding ORMP

Pinnacle Financial Group, Inc.'s ORMP Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Oramed Pharmaceuticals (ORMP) in Q3 2026: 984 shares worth $4.6K. The stake represents ﹤0.01% of the portfolio and ranks #1806 among its holdings.

90 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 984 shares of Oramed Pharmaceuticals worth $4.6K as of Q3 2026.
  • Oramed Pharmaceuticals was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1806 holding.
  • 90 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.